ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,473Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 2888

$1.63M Total Retail Price of All Prescriptions

Rank: 54 out of 2888

639 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 639 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

34% of this provider’s 639 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 21,388 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,072 791 S3 1 4
FUROSEMIDE 1,041 893 2 6
LEVOTHYROXINE SODIUM 808 718 3 1
SIMVASTATIN 775 642 4 2
AMLODIPINE BESYLATE 692 587 5 5
DONEPEZIL HCL 678 655 6 26
METOPROLOL TARTRATE 615 497 7 10
OMEPRAZOLE 608 495 8 7
POTASSIUM CHLORIDE 526 450 9 14
MIRTAZAPINE 521 484 10 54
WARFARIN SODIUM 499 470 11 22
NAMENDA 490 477 12 34
QUETIAPINE FUMARATE 445 409 13 66
LISINOPRIL 379 285 14 3
METFORMIN HCL 324 267 15 8
HYDRALAZINE HCL 296 245 16 59
CARVEDILOL 279 241 17 21
GABAPENTIN 278 240 18 13
ZOLPIDEM TARTRATE 269 158 19 17
TRAZODONE HCL 253 217 20 43
TRAMADOL HCL 252 214 21 16
LIDODERM 238 218 22 105
CYMBALTA 235 201 23 44
NOVOLOG 227 186 24 114
SERTRALINE HCL 226 176 25 27
RISPERIDONE 226 211 25 72
CLOPIDOGREL 221 179 27 30
METOPROLOL SUCCINATE 220 176 28 11
TAMSULOSIN HCL 216 195 29 29
PAROXETINE HCL 198 151 30 84
DIVALPROEX SODIUM 198 190 30 100
SPIRONOLACTONE 197 161 32 70
LACTULOSE 191 161 33 111
CLONIDINE HCL 190 133 34 39
LEVETIRACETAM 177 76 35 103
ISOSORBIDE MONONITRATE ER 176 159 36 51
LYRICA 176 124 36 69
CITALOPRAM HBR 175 140 38 24
PLAVIX 165 132 39 40
PRAVASTATIN SODIUM 165 105 39 12
PANTOPRAZOLE SODIUM 164 120 41 33
LEVEMIR 162 127 42 135
PREDNISONE 161 111 43 42
SEROQUEL 156 135 44 143
BACLOFEN 152 45 45 121
LEVOFLOXACIN 151 120 46 57
ATORVASTATIN CALCIUM 151 105 46 9
ESCITALOPRAM OXALATE 147 137 48 62
CARBIDOPA-LEVODOPA 147 147 48 113
NEXIUM 144 120 50 19
ATENOLOL 141 118 51 25
MELOXICAM 133 121 52 31
DIOVAN 124 105 53 35
PROMETHAZINE HCL 121 96 R 54 96
FAMOTIDINE 121 104 54 75
FENTANYL 120 95 S2 56 126
LANTUS 117 89 57 45
ALENDRONATE SODIUM 116 111 58 23
FLUTICASONE PROPIONATE 114 102 59 32
OXYBUTYNIN CHLORIDE 113 105 60 124
AMIODARONE HCL 111 99 61 167
GLIMEPIRIDE 108 88 62 36
NOVOLIN R 106 95 63 109
EXELON 106 106 63 106
LOSARTAN POTASSIUM 101 70 65 18
ALLOPURINOL 99 65 66 37
ALBUTEROL SULFATE 98 73 67 134
NIFEDIPINE ER 96 66 68 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 66 68 28
SANTYL 96 46 68 210
ROPINIROLE HCL 90 66 71 115
HYDROCHLOROTHIAZIDE 89 61 72 15
AZITHROMYCIN 89 60 72 38
DIGOXIN 88 64 74 55
LATANOPROST 88 84 74 197
GEMFIBROZIL 87 54 76 98
LOSARTAN-HYDROCHLOROTHIAZIDE 87 62 76 46
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 58 76 88
CRESTOR 87 63 76 20
IPRATROPIUM BROMIDE 86 72 80 188
GLYBURIDE 85 84 R 81 58
CIPROFLOXACIN HCL 82 53 82 47
SUCRALFATE 79 59 83 187
IPRATROPIUM-ALBUTEROL 76 65 84 150
HYDROXYZINE HCL 75 68 R 85 174
NYSTATIN 75 60 85 178
PHENYTOIN SODIUM EXTENDED 71 54 87 128
SPIRIVA 71 59 87 79
CEPHALEXIN 68 61 89 119
TRICOR 68 50 89 91
TIZANIDINE HCL 68 20 89 133
POLYETHYLENE GLYCOL 3350 67 53 92 93
OXYBUTYNIN CHLORIDE ER 66 41 93 132
FLUOXETINE HCL 66 43 93 83
ISOSORBIDE DINITRATE 64 50 95 290
ABILIFY 63 38 96 172
BUSPIRONE HCL 62 48 97 148
NOVOLOG FLEXPEN 61 44 98 171
LEVEMIR FLEXPEN 61 38 98 156
METOCLOPRAMIDE HCL 60 30 100 116
BETAMETHASONE DIPROPIONATE 59 55 101 314
HYDROMORPHONE HCL 59 39 S2 101 332
NITROFURANTOIN MONO-MACRO 58 55 103 162
ADVAIR DISKUS 56 41 104 60
VALPROIC ACID 56 25 104 278
RANITIDINE HCL 56 54 104 56
HUMALOG 56 33 104 166
PROPRANOLOL HCL 55 39 108 164
DETROL LA 55 49 108 192
CLINDAMYCIN HCL 55 41 108 253
AVODART 54 45 111 151
JANTOVEN 53 48 112 163
VESICARE 53 45 112 154
SINGULAIR 52 35 114 85
HALOPERIDOL 52 42 114 282
BENZTROPINE MESYLATE 52 37 R 114 191
CYCLOBENZAPRINE HCL 51 38 R 117 68
BYSTOLIC 50 42 118 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.